CSACI position statement: transition recommendations on existing epinephrine autoinjectors.
- DOI
- 10.1186/s13223-021-00634-2
- Published
- 2021 Dec 13
- Container
- Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13223-021-00634-2,
title = {CSACI position statement: transition recommendations on existing epinephrine autoinjectors.},
author = {Li LDX and Abrams EM and Lavine E and Hildebrand K and Mack DP},
year = {2021},
journal = {Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology},
doi = {10.1186/s13223-021-00634-2},
url = {https://doi.org/10.1186/s13223-021-00634-2}
}RIS
TY - JOUR TI - CSACI position statement: transition recommendations on existing epinephrine autoinjectors. AU - Li LDX AU - Abrams EM AU - Lavine E AU - Hildebrand K AU - Mack DP PY - 2021 JO - Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology DO - 10.1186/s13223-021-00634-2 UR - https://doi.org/10.1186/s13223-021-00634-2 ER -
APA
LDX, L., EM, A., E, L., K, H., & DP, M. (2021). CSACI position statement: transition recommendations on existing epinephrine autoinjectors.. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. https://doi.org/10.1186/s13223-021-00634-2
Source records
- pubmed · retrieved 2026-09-27T16:47:56.326Z